Obesity

Short‐term complications and post‐acute sequelae in hospitalized paediatric patients with COVID‐19 and obesity: A multicenter cohort study

Pediatr ObesPublished Multicentre retrospective cohort study

Authors' conclusion

In paediatric hospitalized patients with COVID-19, severe short-term outcomes and post-acute sequelae are associated with obesity. Recognizing obesity as a key comorbidity is essential to develop targeted strategies for prevention of COVID-19 complications in children.

Study context

Population
Hospitalized paediatric patients with SARS-CoV-2 RT-PCR-confirmed COVID-19, 3 tertiary hospitals, March 2020–December 202167 (31.02%) with obesity
Participants
216 patients
Exposure
Obesity vs no obesity
  • Obesityn = 67
Outcome
Short-term outcomes: ICU admission, ventilatory support, superinfections, acute kidney injury and mortality; post-acute sequelae beyond 4 weeks from symptom onset
Methodological detailsobservational, three tertiary hospitals
  • Observational
  • Three tertiary hospitals

Main finding

As reported in the abstract

Short-term complications
Each group vs no obesityEstimate (95% CI)
Obesity
aOR (ICU admission) 5.63(2.90–10.94)
Obesity
aOR (oxygen requirement) 2.77(1.36–5.63)
Obesity
aOR (non-invasive ventilatory support) 6.81(2.11–22.04)
Obesity
aOR (overall superinfections) 3.02(1.45–6.31)
Obesity
aOR (suspected bacterial pneumonia) 3.00(1.44–6.23)

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Post-acute sequelae · beyond 4 weeks from symptom onsetObesityvs No obesityaOR (dyspnea) 9.91 (95% CI 1.92–51.10)
Post-acute sequelae · beyond 4 weeks from symptom onsetObesityvs No obesityaOR (muscle weakness) 20.04 (95% CI 2.50–160.65)

Original publication

Short‐term complications and post‐acute sequelae in hospitalized paediatric patients with COVID‐19 and obesity: A multicenter cohort study. Pediatr Obes. Published 12 October 2022. doi:10.1111/ijpo.12980

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.